# Noom reviews (2026): GLP-1 telehealth sellers | This GLP

The intro runs three weeks, the medication four, and the recurring charge answers to twelve.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/noom
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Three clocks in one footnote

# Noom review

The intro runs three weeks, the medication four, and the recurring charge answers to twelve.

## The verdict

Noom's own footnote sets an initial three-week subscription bundled with four weeks of medication from $79, then $179 a month against a twelve-week subscription thereafter. The tirzepatide program is built identically at $149 and $349. The recurring figure is not a cancel-anytime monthly rate.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $195/mo

Prescription

Required

Compounded

Yes — not FDA-approved

Noom sells a behavior-change program with compounded GLP-1 prescribing attached. The medication and the subscription are separate products billed on different schedules.

1.  ## Who writes the prescription, and what do they see?
    
    A prescription follows an eligibility review, and the program is presented as coaching first with medication as one component. Who writes the prescription is not named on the pricing pages, and what a clinician reviews before approving a dose is not described.
    
    The coaching program is the thing Noom is known for, and the GLP-1 offer is layered onto it. That layering is why the terms run on different clocks: the subscription and the medication were never one product.
    
2.  ## What happens when the dose goes up?
    
    Nothing published ties a dose to either figure, so what four weeks of medication contains at the start and at maintenance is not stated. A buyer stepping up inside a twelve-week subscription cannot tell from the pages whether the medication charge moves with them.
    
3.  ## What the price includes
    
    Three weeks of subscription plus four weeks of medication is $79 to begin, which covers neither a calendar month nor a matching pair of terms. After that the charge is $179 a month, but the commitment underneath it is twelve weeks. Tirzepatide follows at $149 and $349. A reader comparing $179 against another seller's monthly rate is comparing a twelve-week term against a one-month one. Spread over the 84 days it buys, it is $195 a calendar month.
    
4.  ## What it claims, and what it cites
    
    The GLP-1 lines are compounded rather than manufactured, and no compounding pharmacy is named. The FDA does not review a compounded preparation before it is dispensed.
    

## Where it holds up, and where it does not

-   Strength: The terms are disclosed in a footnote
-   Strength: Coaching is built in rather than sold apart
-   Strength: Both molecules are offered
-   Limitation: Three different term lengths in one sentence
-   Limitation: The recurring charge assumes twelve weeks
-   Limitation: Intro subscription and medication run unequal terms
-   Limitation: No compounding pharmacy is named

## What the evidence says about this kind of treatment

The assessment above is about Noom. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A buyer who reads the footnote before the headline.

Wrong for

A buyer who needs a cancel-anytime monthly rate.

## The evidence behind what Noom prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Noom compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Calibrate Health | Insured buyers who want coaching and insurance handling alongside a prescription |  |
| Queen RX | Buyers content to commit a quarter at a time in one payment |  |
| LaSara Medical Group | Buyers who can pay a full term at once and want the lowest rung |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Onyx Weight Loss](https://thisglp.com/reviews/onyx-weight-loss) [Open Water Rx](https://thisglp.com/reviews/open-water-rx) [Optimized Health](https://thisglp.com/reviews/optimized-health) [Options Medical Weight Loss](https://thisglp.com/reviews/options-medical-weight-loss) [OrderlyMeds](https://thisglp.com/reviews/orderlymeds) [Oria Meds](https://thisglp.com/reviews/oria-meds)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Is $179 a month cancel-anytime?

Noom's footnote charges it against a twelve-week subscription, so the commitment underneath the monthly figure is a quarter.

What does the intro price cover?

A three-week subscription bundled with four weeks of medication, from $79 for semaglutide and $149 for tirzepatide.

Why do the terms not line up?

The subscription and the medication are separate products on separate schedules, and the footnote prices them in one sentence.

Is Noom expensive compared with other GLP-1 telehealth sellers?

Noom publishes a starting figure of $195/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Noom above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
